Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Late-breaking trial of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: ESPRIT, PARAGON B, and Second Symphony Series

Late-breaking trial of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: ESPRIT, PARAGON B, and Second Symphony Series. Pfeffer MA, series editor. Cardiology Scientific Update. 2000.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.